MXL
Published on 07/11/2025 at 05:34
October 24, 2019
CARLSBAD, Calif.--(BUSINESS WIRE)-- MaxLinear, Inc. (NYSE: MXL), a leading provider of RF, analog and mixed-signal integrated circuits for the connected home, and industrial and multi-market applications, today announced financial results for the third quarter ended September 30, 2019.
GAAP basis:
$56.4 million in the year-ago quarter, or 66% of net revenue.
Non-GAAP basis:
$32.8 million or 40% of revenue in the prior quarter, and $35.6 million or 42% of revenue in the year-ago quarter.
to develop sub-3.5W 100G single lambda DR, FR, and LR optical modules.
"In the third quarter, revenue results were in line with our guidance, gross margin remained solid, and operating expenses declined on disciplined execution. We also generated more than $21 million in cash from operations. We are focused on delivering our new 5G wireless radio and fiber-optic datacenter high-speed interconnect products as we expand into new large, high-growth infrastructure markets," commented Kishore Seendripu, Ph.D., Chairman and CEO.
"We are excited to confirm our first 5G wireless radio-platform design-win at a tier-1 wireless OEM for our industry leading 14nm CMOS 4x4 Quad RF transceiver system-on-chip solution. Early customer evaluation feedback across major OEMs confirms that we are hitting the mark on the feature sets required by this demanding market. We are on track to see initial revenues in 2020 for the 5G market enabled by significant content increases per base station. In early 2020, we also expect production adoption of our 100 gigabit and 400 gigabit PAM4 DSP SoCs in the hyperscale data center market." continued Dr. Seendripu.
The company expects revenue in the fourth quarter 2019 to be approximately $67 million to
$73 million. The Company also estimates the following:
MaxLinear will host its third quarter financial results conference call today, October 24, 2019 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-407-3109 / International: 1-201-493-6798. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at https://investors.maxlinear.com, and will be archived and available after the call at https://investors.maxlinear.com until November 7, 2019. A replay of the conference call will also be available until November 7, 2019 by dialing US toll free: 1-877-660-6853 / International: 1-201-612-7415 and Conference ID#: 13692485.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including specifically our current guidance for fourth quarter 2019 revenue, gross margins, and operating expenses) and statements
concerning expectations of potential developments in our target markets, including management's views with respect to the prospects for and trends in our connected home and 5G wireless and fiber-optic high-speed interconnect infrastructure markets. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. Forward-looking statements are based on management's current, preliminary expectations and are subject to various risks and uncertainties. Risks and uncertainties affecting our business and future operating results include, without limitation, intense competition in our industry; our dependence on a limited number of customers for a substantial portion of our revenues; uncertainties concerning how end user markets for our products will develop, including in particular new markets we are entering such as the 5G wireless and fiber-optic data center high-speed interconnect infrastructure markets but also existing markets such as connected home; uncertainties concerning the outcome of global trade negotiations, export control limitations, and heightened geopolitical risks generally; potential uncertainties arising from continued consolidation among cable television and satellite operators in our target markets and continued consolidation among competitors within the semiconductor industry generally; our ability to develop and introduce new and enhanced products on a timely basis and achieve market acceptance of those products, particularly as we seek to expand outside of our historic markets; potential decreases in average selling prices for our products; risks relating to intellectual property protection and the prevalence of intellectual property litigation in our industry; the impact on our financial condition of the indebtedness arising from the Exar transaction; our reliance on a limited number of third party manufacturers; and our lack of long-term supply contracts and dependence on limited sources of supply.
In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our most recent Annual Report on Form 10-K for the year ended December 31, 2018 filed with the SEC on February 5, 2019, our Quarterly Reports on Form 10-Q for the quarter ended March 31, 2019 filed with the SEC on May 1, 2019 and for the quarter ended June 30, 2019 filed with the SEC on July 25, 2019, and our Current Reports on Form 8-K, as well as the information to be set forth under the caption "Risk Factors" in MaxLinear's Quarterly Report on Form 10-Q for the quarter ended September 30, 2019, which we expect to file shortly. All forward-looking statements are based on the estimates, projections and assumptions of management as of October 24, 2019, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.
To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including non-GAAP gross margin, operating expenses, operating expenses as a percentage of revenue, income from operations as percentage of revenue, effective tax rate, net income and diluted earnings per share. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance based bonus plan for 2019, which we currently intend to settle in shares of our common stock; (iii) accruals related to our performance based bonus plan for 2018 which we settled in shares of common stock in 2019; (iv) amortization of purchased intangible assets; (v) depreciation of fixed assets step-
up; (vi) professional fees and settlement costs related to our previously disclosed IP and commercial litigation matters; (vii) severance and other restructuring charges; (viii) non-cash income tax benefits and expenses and effects of the 2017 Tax Cuts and Jobs Act, or Tax Act, as applicable; and (ix) non-recurring gain on reversal of liability. These non-GAAP measures are not in accordance with and do not serve as an alternative for GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. These non-GAAP measures should only be viewed in conjunction with corresponding GAAP measures. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.
We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management's incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.
The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:
Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income.
Bonuses under our executive and non-executive bonus programs have been excluded from our non-GAAP net income for all periods reported. Bonus payments for the 2018 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in February 2019. We currently expect that bonus awards under our fiscal 2019 program will be settled in common stock in the first quarter of fiscal 2020.
Expenses incurred (gains recognized) in relation to acquisitions include amortization of purchased intangible assets, depreciation of step-up of property and equipment to fair value, and non-recurring gain on reversal of liability for an assumed indemnification obligation.
Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to exiting certain facilities.
Expenses incurred in relation to our intellectual property and commercial litigation include professional fees incurred.
Income tax benefits and expense adjustments are those that do not affect cash income taxes payable. Effects of the Tax Act were excluded from non-GAAP effective tax rate, as
applicable.
Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, particularly related to stock-based compensation and its related tax effects as well as potential impairments, we have not provided a reconciliation for non-GAAP guidance provided for the fourth quarter 2019.
MaxLinear, Inc. (NYSE:MXL) is a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit https://www.maxlinear.com.
MXL is MaxLinear's registered trademark. Other trademarks appearing herein are the property of their respective owners.
Net revenue
$ 80,020
$ 82,507
$ 85,010
Cost of net revenue
38,116
38,427
41,134
Gross profit
41,904
44,080
43,876
Operating expenses:
Research and development
23,174
24,304
29,047
Selling, general and administrative
21,920
22,327
24,963
Impairment losses
-
-
2,198
Restructuring charges
144
416
236
Total operating expenses
45,238
47,047
56,444
Loss from operations
(3,334)
(2,967)
(12,568)
Interest income
214
192
17
Interest expense
(2,718)
(2,853)
(3,473)
Other income (expense), net
1,098
(14)
39
Total interest and other expense, net
(1,406)
(2,675)
(3,417)
Loss before income taxes
(4,740)
(5,642)
(15,985)
Income tax benefit
(26)
(3,413)
(2,050)
Net loss
$ (4,714)
$ (2,229)
$ (13,935)
Net loss per share:
Basic
$ (0.07)
$ (0.03)
$ (0.20)
Diluted
$ (0.07)
$ (0.03)
$ (0.20)
Shares used to compute net loss per share:
Basic
71,366
70,917
68,742
Diluted
71,366
70,917
68,742
Net revenue
$ 247,162
$ 297,370
Cost of net revenue
116,101
134,496
Gross profit
131,061
162,874
Operating expenses:
Research and development
74,877
90,379
Selling, general and administrative
67,838
76,581
Impairment losses
-
2,198
Restructuring charges
2,477
2,101
Total operating expenses
145,192
171,259
Loss from operations
(14,131)
(8,385)
Interest income
553
54
Interest expense
(8,546)
(11,061)
Other income (expense), net
429
193
Total interest and other expense, net
(7,564)
(10,814)
Loss before income taxes
(21,695)
(19,199)
Income tax provision (benefit)
(9,901)
7,311
Net loss
$ (11,794)
$ (26,510)
Net loss per share:
Basic
$ (0.17)
$ (0.39)
Diluted
$ (0.17)
$ (0.39)
Shares used to compute net loss per share:
Basic
70,755
68,256
Diluted
70,755
68,256
September 30,
2019
June 30,
2019
September 30,
2018
Operating Activities
Net loss
$ (4,714)
$ (2,229)
$ (13,935)
Adjustments to reconcile net loss to net cash provided by operating activities:
Amortization and depreciation
16,419
16,646
19,767
Impairment losses
-
-
2,198
Amortization of debt issuance costs and accretion of discount on debt and leases
380
391
287
Stock-based compensation
8,359
8,207
7,940
Deferred income taxes
(1,379)
(4,600)
304
Loss on disposal of property and equipment
-
11
-
Gain on foreign currency
(183)
(54)
(184)
Excess tax benefits on stock-based awards
(61)
(2,074)
(93)
Changes in operating assets and liabilities:
Accounts receivable
280
3,022
25,016
Inventory
5,108
(122)
2,581
Prepaid expenses and other assets
960
(648)
712
Leased right-of-use assets
1,309
981
-
Accounts payable, accrued expenses and other current liabilities
(6,313)
2,961
(10,606)
Accrued compensation
730
(209)
2,671
Accrued price protection liability
2,291
(7,649)
(5,662)
Lease liabilities
(2,183)
(2,179)
-
Other long-term liabilities
749
(11)
(275)
Net cash provided by operating activities
21,752
12,444
30,721
Investing Activities
Purchases of property and equipment
(1,219)
(524)
(1,609)
Purchases of intangible assets
(86)
-
-
Net cash used in investing activities
(1,305)
(524)
(1,609)
Financing Activities
Repayment of debt
(20,000)
(15,000)
(35,000)
Net proceeds from issuance of common stock
288
3,305
91
Minimum tax withholding paid on behalf of employees for restricted stock units
(1,339)
(5,408)
(1,178)
Net cash used in financing activities
(21,051)
(17,103)
(36,087)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
90
354
103
Decrease in cash, cash equivalents and restricted cash
(514)
(4,829)
(6,872)
Cash, cash equivalents and restricted cash at beginning of period
67,038
71,867
75,115
Cash, cash equivalents and restricted cash at end of period
$ 66,524
$ 67,038
$ 68,243
Operating Activities
Net loss
$ (11,794)
$ (26,510)
Adjustments to reconcile net loss to cash provided by operating activities:
Amortization and depreciation
49,928
59,902
Impairment losses
-
2,198
Amortization of debt issuance costs and accretion of discount on debt and leases
1,173
861
Stock-based compensation
24,313
23,722
Deferred income taxes
(12,455)
(3,317)
Loss on disposal of property and equipment
46
-
Impairment of leasehold improvements
1,442
700
Impairment of long-lived assets
2,182
-
Gain on extinguishment of lease liabilities
(2,880)
-
(Gain) loss on foreign currency
330
(541)
Excess tax benefits on stock-based awards
(3,872)
(1,208)
Changes in operating assets and liabilities:
Accounts receivable
3,160
7,462
Inventory
3,971
11,677
Prepaid expenses and other assets
916
3,928
Leased right-of-use assets
2,935
-
Accounts payable, accrued expenses and other current liabilities
(1,431)
513
Accrued compensation
1,414
6,574
Deferred revenue and deferred profit
-
(138)
Accrued price protection liability
(2,869)
(7,153)
Lease liabilities
(6,487)
-
Other long-term liabilities
219
(154)
Net cash provided by operating activities
50,241
78,516
Investing Activities
Purchases of property and equipment
(3,898)
(6,413)
Purchases of intangible assets
(86)
-
Net cash used in investing activities
(3,984)
(6,413)
Financing Activities
Repayment of debt
(50,000)
(78,000)
Net proceeds from issuance of common stock
6,221
4,107
Minimum tax withholding paid on behalf of employees for restricted stock units
(11,166)
(5,017)
Net cash used in financing activities
(54,945)
(78,910)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
1,021
638
Decrease in cash, cash equivalents and restricted cash
(7,667)
(6,169)
Cash, cash equivalents and restricted cash at beginning of period
74,191
74,412
Cash, cash equivalents and restricted cash at end of period
$ 66,524
$ 68,243
September 30, 2019
June 30, 2019
September
30, 2018 (1)
Assets
Current assets:
Cash and cash equivalents
$ 66,115
$ 66,629
$
67,185
Short-term restricted cash
345
344
349
Accounts receivable, net
56,339
56,618
58,633
Inventory
37,642
42,875
41,757
Prepaid expenses and other current assets
4,679
6,184
6,329
Total current assets
165,120
172,650
174,253
Long-term restricted cash
64
65
709
Property and equipment, net
15,204
15,738
19,413
Leased right-of-use assets
18,719
20,624
-
Intangible assets, net
202,217
216,342
261,813
Goodwill
238,330
238,330
238,330
Deferred tax assets
64,046
62,667
42,691
Other long-term assets
3,065
2,744
4,935
Total assets
$ 706,765
$ 729,160
$
742,144
Liabilities and stockholders' equity
Current liabilities
$ 63,119
$ 66,918
$
66,464
Long-term lease liabilities
14,995
16,515
-
Long-term debt
206,622
226,335
270,470
Other long-term liabilities
8,678
8,016
12,816
Stockholders' equity
413,351
411,376
392,394
Total liabilities and stockholders' equity
$ 706,765
$ 729,160
$
742,144
(1) Long-term lease liabilities have been reclassified from other long-term liabilities to conform to current period presentation.
GAAP gross profit
$ 41,904
$ 44,080
$ 43,876
Stock-based compensation
151
147
131
Performance based equity
-
-
53
Amortization of purchased intangible assets
8,477
8,478
8,969
Depreciation of fixed asset step-up
-
-
95
Non-GAAP gross profit
50,532
52,705
53,124
GAAP R&D expenses
23,174
24,304
29,047
Stock-based compensation
(4,155)
(4,222)
(4,726)
Performance based equity
(45)
-
(1,517)
Depreciation of fixed asset step-up
-
-
(321)
Non-GAAP R&D expenses
18,974
20,082
22,483
GAAP SG&A expenses
21,920
22,327
24,963
Stock-based compensation
(4,068)
(3,823)
(3,070)
Performance based equity
(279)
-
(785)
Amortization of purchased intangible assets
(5,722)
(5,792)
(7,994)
Depreciation of fixed asset step-up
-
-
(12)
IP litigation costs, net
(71)
(13)
(19)
Non-GAAP SG&A expenses
11,780
12,699
13,083
GAAP impairment losses
- -
2,198
Impairment losses
- -
(2,198)
Non-GAAP impairment losses
-
-
-
GAAP restructuring expenses
144
416
236
Restructuring charges
(144)
(416)
(236)
Non-GAAP restructuring expenses
-
-
-
GAAP loss from operations
(3,334)
(2,967)
(12,568)
Total non-GAAP adjustments
23,112
22,891
30,126
Non-GAAP income from operations
19,778
19,924
17,558
GAAP and non-GAAP interest and other income (expense), net
(1,406)
(2,675)
(3,417)
Non-recurring gain on reversal of liability
(1,006)
-
-
Non-GAAP interest and other income (expense), net
(2,412)
(2,675)
(3,417)
GAAP loss before income taxes
(4,740)
(5,642)
(15,985)
Total non-GAAP adjustments
22,106
22,891
30,126
Non-GAAP income before income taxes
17,366
17,249
14,141
GAAP income tax benefit
(26)
(3,413)
(2,050)
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act
894
4,621
3,040
Non-GAAP income tax provision
868
1,208
990
GAAP net loss
(4,714)
(2,229)
(13,935)
Total non-GAAP adjustments before income taxes
22,106
22,891
30,126
Less: total tax adjustments
894
4,621
3,040
Non-GAAP net income
$ 16,498
$ 16,041
$ 13,151
Shares used in computing non-GAAP basic net income per share
71,366
70,917
68,742
Shares used in computing non-GAAP diluted net income per share
72,506
72,389
70,634
Non-GAAP basic net income per share
$ 0.23
$ 0.23
$ 0.19
Non-GAAP diluted net income per share
$ 0.23
$ 0.22
$ 0.19
GAAP gross profit
$ 131,061
$ 162,874
Stock-based compensation
428
357
Performance based equity
73
178
Amortization of purchased intangible assets
25,379
26,906
Depreciation of fixed asset step-up
-
303
Non-GAAP gross profit
156,941
190,618
GAAP R&D expenses
74,877
90,379
Stock-based compensation
(12,590)
(13,554)
Performance based equity
(970)
(3,954)
Depreciation of fixed asset step-up
(6)
(974)
Non-GAAP R&D expenses
61,311
71,897
GAAP SG&A expenses
67,838
76,581
Stock-based compensation
(11,295)
(9,798)
Performance based equity
(1,218)
(2,564)
Amortization of purchased intangible assets
(17,312)
(23,982)
Depreciation of fixed asset step-up
-
(34)
IP litigation costs, net
(84)
(80)
Non-GAAP SG&A expenses
37,929
40,123
GAAP impairment losses
-
2,198
Impairment losses
-
(2,198)
Non-GAAP impairment losses
-
-
GAAP restructuring expenses
2,477
2,101
Restructuring charges
(2,477)
(2,101)
Non-GAAP restructuring expenses
-
-
GAAP loss from operations
(14,131)
(8,385)
Total non-GAAP adjustments
71,832
86,983
Non-GAAP income from operations
57,701
78,598
GAAP and non-GAAP interest and other income (expense), net
(7,564)
(10,814)
Non-recurring gain on reversal of liability
(1,006)
-
Non-GAAP interest and other income (expense), net
(8,570)
(10,814)
GAAP loss before income taxes
(21,695)
(19,199)
Total non-GAAP adjustments
70,826
86,983
Non-GAAP income before income taxes
49,131
67,784
GAAP income tax provision (benefit)
(9,901)
7,311
Adjustment for non-cash tax benefits/expenses and effects of the Tax Act
12,993
(2,566)
Non-GAAP income tax provision
3,092
4,745
GAAP net loss
(11,794)
(26,510)
Total non-GAAP adjustments before income taxes
70,826
86,983
Less: total tax adjustments
12,993
(2,566)
Non-GAAP net income
$ 46,039
$ 63,039
Shares used in computing non-GAAP basic net income per share
70,755
68,256
Shares used in computing non-GAAP diluted net income per share
72,270
70,521
Non-GAAP basic net income per share
$ 0.65
$ 0.92
Non-GAAP diluted net income per share
$ 0.64
$ 0.89
September 30,
June 30,
September 30,
2019
2019
2018
GAAP gross profit
52.4%
53.4%
51.6%
Stock-based compensation
0.2%
0.2%
0.2%
Performance based equity
-%
-%
0.1%
Amortization of purchased intangible assets
10.6%
10.3%
10.6%
Depreciation of fixed asset step-up
-%
-%
0.1%
Non-GAAP gross profit
63.1%
63.9%
62.5%
GAAP R&D expenses
29.0%
29.5%
34.2%
Stock-based compensation
(5.2)%
(5.1)%
(5.6)%
Performance based equity
(0.1)%
-%
(1.8)%
Depreciation of fixed asset step-up
-%
-%
(0.5)%
Non-GAAP R&D expenses
23.7%
24.3%
26.4%
GAAP SG&A expenses
27.4%
27.1%
29.4%
Stock-based compensation
(5.1)%
(4.6)%
(3.6)%
Performance based equity
(0.3)%
-%
(0.9)%
Amortization of purchased intangible assets
(7.2)%
(7.0)%
(9.4)%
Depreciation of fixed asset step-up
-%
-%
-%
IP litigation costs, net
(0.1)%
-%
-%
Non-GAAP SG&A expenses
14.7%
15.4%
15.4%
GAAP impairment losses
-%
-%
2.6%
Impairment losses
-%
-%
(2.6)%
Non-GAAP impairment losses
-%
-%
-%
GAAP restructuring expenses
0.2%
0.5%
0.3%
Restructuring charges
(0.2)%
(0.5)%
(0.3)%
Non-GAAP restructuring expenses
-%
-%
-%
GAAP loss from operations
(4.2)%
(3.6)%
(14.8)%
Total non-GAAP adjustments
28.9%
27.7%
35.4%
Non-GAAP income from operations
24.7%
24.1%
20.7%
GAAP interest and other income (expense), net
(1.8)%
(3.2)%
(4.0)%
Nonrecurring gain on reversal of liability
(1.3)%
-%
-%
Non-GAAP interest and other income (expense), net
(3.0)%
(3.2)%
(4.0)%
GAAP loss before income taxes
(5.9)%
(6.8)%
(18.8)%
Total non-GAAP adjustments before income taxes
27.6%
27.7%
35.4%
Non-GAAP income before income taxes
21.7%
20.9%
16.6%
GAAP income tax benefit
-%
(4.1)%
(2.4)%
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act
1.1%
5.6%
3.6%
Non-GAAP income tax provision
1.1%
1.5%
1.2%
GAAP net loss
(5.9)%
(2.7)%
(16.4)%
Total non-GAAP adjustments before income taxes
27.6%
27.7%
35.4%
Less: total tax adjustments
1.1%
5.6%
3.6%
Non-GAAP net income
20.6%
19.4%
15.5%
GAAP gross profit
53.0%
54.8%
Stock-based compensation
0.2%
0.1%
Performance based equity
-%
0.1%
Amortization of purchased intangible assets
10.3%
9.0%
Depreciation of fixed asset step-up
-%
0.1%
Non-GAAP gross profit
63.5%
64.1%
GAAP R&D expenses
30.3%
30.4%
Stock-based compensation
(5.1)%
(4.6)%
Performance based equity
(0.4)%
(1.3)%
Depreciation of fixed asset step-up
-%
(0.3)%
Non-GAAP R&D expenses
24.8%
24.2%
GAAP SG&A expenses
27.4%
25.8%
Stock-based compensation
(4.6)%
(3.3)%
Performance based equity
(0.5)%
(0.9)%
Amortization of purchased intangible assets
(7.0)%
(8.1)%
Depreciation of fixed asset step-up
-%
-%
IP litigation costs, net
-%
-%
Non-GAAP SG&A expenses
15.3%
13.5%
GAAP impairment losses
-%
0.7%
Impairment losses
-%
(0.7)%
Non-GAAP impairment losses
-%
-%
GAAP restructuring expenses
1.0%
0.7%
Restructuring charges
(1.0)%
(0.7)%
Non-GAAP restructuring expenses
-%
-%
GAAP loss from operations
(5.7)%
(2.8)%
Total non-GAAP adjustments
29.1%
29.3%
Non-GAAP income from operations
23.3%
26.4%
GAAP interest and other income (expense), net
(3.1)%
(3.6)%
Nonrecurring gain on reversal of liability
(0.4)%
-%
Non-GAAP interest and other income (expense), net
(3.5)%
(3.6)%
GAAP loss before income taxes
(8.8)%
(6.5)%
Total non-GAAP adjustments before income taxes
28.7%
29.3%
Non-GAAP income before income taxes
19.9%
22.8%
GAAP income tax provision (benefit)
(4.0)%
2.5%
Adjustment for non-cash tax benefits/expenses and the effects of the Tax Act
5.3%
(0.9)%
Non-GAAP income tax provision
1.3%
1.6%
GAAP net loss
(4.8)%
(8.9)%
Total non-GAAP adjustments before income taxes
28.7%
29.3%
Less: total tax adjustments
5.3%
(0.9)%
Non-GAAP net income
18.6%
21.2%
View source version on businesswire.com: https://www.businesswire.com/news/home/20191024005912/en/
Steven Litchfield Tel: 949-333-0080
[email protected] Source: MaxLinear, Inc.
Disclaimer
MaxLinear Inc. published this content on July 11, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 11, 2025 at 09:33 UTC.